Citius Pharmaceuticals, Inc. ( CTXR) - Key Metrics
CTXR Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0.06 | -$0.46 | $0 | $0 |
| 2026Q2 | $0.07 | -$0.95 | -$0.06 | -$0.06 |
| 2026Q1 | $0.18 | -$0.38 | -$0.61 | -$0.61 |
| 2025Q4 | $0 | -$0.44 | -$0.66 | -$0.66 |
| 2025Q3 | $0 | -$0.80 | -$0.49 | -$0.49 |
CTXR Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | -0.44 |
| 2026Q2 | 0% | -0.24 |
| 2026Q1 | 0% | -0.51 |
| 2025Q4 | 0% | -0.70 |
| 2025Q3 | 0% | -0.50 |
CTXR
Price: $0.57
52 week price:
Earnings Per Share: -2.14 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 674400
Ebitda: -9.5 millionMarket Capitalization: 20.7 million